Skip to main content
. Author manuscript; available in PMC: 2011 Jul 29.
Published in final edited form as: Am J Physiol Heart Circ Physiol. 2008 Mar 21;294(5):H2053–H2059. doi: 10.1152/ajpheart.91529.2007

Fig. 6.

Fig. 6

SP-D mRNA levels are increased in HCASMCs by LPS and TNF-α. HCASMCs were treated with either LPS (2 ng/ml, solid line) or TNF-α (2 ng/ml, dashed line) for 2–24 h. SP-D mRNA levels were assessed by real-time PCR. Data were normalized to the level of SP-D mRNA in control (untreated) cells harvested at time 0. Data represent the average increase in the relative amount of SP-D mRNA in 2 experiments with duplicate samples collected at each time point.